G6PC3
Glucose-6-phosphatase 3
Also known as: G6PC3_HUMAN, UGRP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BUM1
- Gene
- G6PC3
- Ensembl
- ENSG00000141349
- Chromosome
- 17
- Canonical length
- 346 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
This gene encodes the catalytic subunit of glucose-6-phosphatase (G6Pase). G6Pase is located in the endoplasmic reticulum (ER) and catalyzes the hydrolysis of glucose-6-phosphate to glucose and phosphate in the last step of the gluconeogenic and glycogenolytic pathways. Mutations in this gene result in autosomal recessive severe congenital neutropenia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
346 residues, UniProt reviewed canonical sequence.
>Q9BUM1|G6PC3
1 MESTLGAGIV IAEALQNQLA WLENVWLWIT FLGDPKILFL FYFPAAYYAS RRVGIAVLWI
61 SLITEWLNLI FKWFLFGDRP FWWVHESGYY SQAPAQVHQF PSSCETGPGS PSGHCMITGA
121 ALWPIMTALS SQVATRARSR WVRVMPSLAY CTFLLAVGLS RIFILAHFPH QVLAGLITGA
181 VLGWLMTPRV PMERELSFYG LTALALMLGT SLIYWTLFTL GLDLSWSISL AFKWCERPEW
241 IHVDSRPFAS LSRDSGAALG LGIALHSPCY AQVRRAQLGN GQKIACLVLA MGLLGPLDWL
301 GHPPQISLFY IFNFLKYTLW PCLVLALVPW AVHMFSAQEA PPIHSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against G6PC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 140 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 140 nTPM
- hypothalamus: 91 nTPM
- adrenal gland: 90 nTPM
- pituitary gland: 90 nTPM
- spinal cord: 82 nTPM
- midbrain: 80 nTPM
Single-cell type
- epicardial cells: 205 nCPM
- syncytiotrophoblasts: 84 nCPM
- cytotrophoblasts: 78 nCPM
- epididymal principal cells: 78 nCPM
- hofbauer cells: 73 nCPM
- cardiomyocytes: 73 nCPM
Immune cell
- plasmacytoid DC: 75 nTPM
- myeloid DC: 54 nTPM
- intermediate monocyte: 44 nTPM
- classical monocyte: 33 nTPM
- non-classical monocyte: 27 nTPM
- total PBMC: 17 nTPM
Brain region
- pons: 94 nTPM
- choroid plexus: 85 nTPM
- midbrain: 72 nTPM
- hypothalamus: 61 nTPM
- white matter: 55 nTPM
- medulla oblongata: 54 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about G6PC3.
Disease | AllUniProt
Conditions G6PC3 is implicated in, by any mechanism.
- Neutropenia, severe congenital 4, autosomal recessive (SCN4) MIM:612541
- Dursun syndrome (DURSS) MIM:612541
Disease | GeneticClinVar
52 pathogenic / likely-pathogenic of 716 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency
- Inherited Immunodeficiency Diseases
- G6PC3-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.7
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads G6PC3 as an antibody target. Whether an autoantibody or antibody against G6PC3 could matter depends on whether native G6PC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
G6PC3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label G6PC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...